Drug Profile
Protein free botulinum toxin A - Medytox
Alternative Names: CoretoxLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Medytox
- Class Botulinum toxins; Muscle relaxants; Skin disorder therapies
- Mechanism of Action Neuromuscular blocking agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Glabellar lines
- Registered Muscle spasticity
Most Recent Events
- 09 Nov 2018 Medy-Tox completes a phase I/III trial in Muscle spasticity in South Korea (Injection) (NCT05164003)
- 09 Nov 2018 Medytox completes a phase III trial for Muscle spasticity in South Korea (Injection) (NCT03289702)
- 17 Jul 2017 Medy-Tox initiates a phase I/III trial in Muscle spasticity in South Korea (Injection) (NCT05164003)